BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 75060)

  • 1. Quantification of bleomycin pulmonary toxicity in mice by changes in lung hydroxyproline content and morphometric histopathology.
    Sikic BI; Young DM; Mimnaugh EG; Gram TE
    Cancer Res; 1978 Mar; 38(3):787-92. PubMed ID: 75060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary toxicity studies of bleomycin and talisomycin.
    Schlein A; Schurig JE; Baca C; Bradner WT; Crooks ST
    Cancer Treat Rep; 1981; 65(3-4):291-7. PubMed ID: 6165468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved therapeutic index of bleomycin when administered by continuous infusion in mice.
    Sikic BI; Collins JM; Mimnaugh EG; Gram TE
    Cancer Treat Rep; 1978 Dec; 62(12):2011-7. PubMed ID: 87269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of exercise on bleomycin-induced pulmonary toxicity in mice.
    Stone DW; Copelan EA; Weisbrode SE; Rozmiarek H
    Cancer Treat Rep; 1986 Sep; 70(9):1067-71. PubMed ID: 2427195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of ascorbic acid supplementation and bleomycin instillation on murine lung connective tissue metabolism.
    Dubick MA; Last JA; Cross CE; Rucker RB
    Drug Nutr Interact; 1983; 2(2):105-15. PubMed ID: 6205840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of repeated administration of N-acetyl-L-cysteine on sulfhydryl levels of different tissues and bleomycin-induced lung fibrosis in hamsters.
    Giri SN; Hyde DM; Schiedt MJ
    J Lab Clin Med; 1988 Jun; 111(6):715-24. PubMed ID: 2453601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin.
    Cabrera S; Gaxiola M; Arreola JL; Ramírez R; Jara P; D'Armiento J; Richards T; Selman M; Pardo A
    Int J Biochem Cell Biol; 2007; 39(12):2324-38. PubMed ID: 17702637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine.
    Nici L; Santos-Moore A; Kuhn C; Calabresi P
    Cancer; 1998 Nov; 83(9):2008-14. PubMed ID: 9806661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of bleomycin-induced lung fibrosis in rats by mesna.
    El-Medany A; Hagar HH; Moursi M; At Muhammed R; El-Rakhawy FI; El-Medany G
    Eur J Pharmacol; 2005 Feb; 509(1):61-70. PubMed ID: 15713430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of collagen deposition following pulmonary oxygen toxicity in the rat by cis-4-hydroxy-L-proline.
    Riley DJ; Berg RA; Edelman NH; Prockop DJ
    J Clin Invest; 1980 Mar; 65(3):643-51. PubMed ID: 6986411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of bleomycin-induced pulmonary fibrosis by a catalytic antioxidant metalloporphyrin.
    Oury TD; Thakker K; Menache M; Chang LY; Crapo JD; Day BJ
    Am J Respir Cell Mol Biol; 2001 Aug; 25(2):164-9. PubMed ID: 11509325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
    Chan P
    Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of pulmonary fibrosis by doxycycline: an experiment with mice].
    Huang YH; Li Y; Shang Y; Ouyang ZG; Zhen YS
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(3):182-6. PubMed ID: 16638326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleomycin induces strain-dependent alterations in the pattern of epithelial cell-specific marker expression in mouse lung.
    Daly HE; Baecher-Allan CM; Barth RK; D'Angio CT; Finkelstein JN
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):303-10. PubMed ID: 9070353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of Ozone (CAS No. 10028-15-6) and Ozone/NNK (CAS No. 10028-15-6/ 64091-91-4) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Oct; 440():1-314. PubMed ID: 12595923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory related changes in lung tissue mechanics after bleomycin-induced lung injury.
    Pinart M; Serrano-Mollar A; Negri EM; Cabrera R; Rocco PR; Romero PV
    Respir Physiol Neurobiol; 2008 Feb; 160(2):196-203. PubMed ID: 17981520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-12p40(-/-) mice treated with intratracheal bleomycin exhibit decreased pulmonary inflammation and increased fibrosis.
    Sakamoto H; Zhao LH; Jain F; Kradin R
    Exp Mol Pathol; 2002 Feb; 72(1):1-9. PubMed ID: 11784117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis.
    Keane MP; Belperio JA; Moore TA; Moore BB; Arenberg DA; Smith RE; Burdick MD; Kunkel SL; Strieter RM
    J Immunol; 1999 May; 162(9):5511-8. PubMed ID: 10228032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.